|Catalog||Size (Price)||Quantity||In Stock||Operation||Other Information|
Orosomucoid 2 Protein Datasheet
ORM2 Protein Price Inquiry ( Available Sizes )
ORM2 Protein Product Information
|Synonym :||ORM2, AGP2|
A DNA sequence encoding the human ORM2 (P19652) (Met1-Ser201) was expressed with a polyhistidine tag at the C-terminus.
|Expression Host:||Human Cells|
ORM2 Protein QC Testing
|Purity:||> 90% as determined by SDS-PAGE||SDS-PAGE:
|Endotoxin:||< 1.0 EU per μg of the protein as determined by the LAL method|
|Stability:||Samples are stable for up to twelve months from date of receipt at -70℃|
|Predicted N terminal:||Gln 19|
The recombinant human ORM2 consists of 194 amino acids and predicts a molecular mass of 23.1 KDa. It migrates as an approximately 23 KDa band in SDS-PAGE under reducing conditions.
|Formulation:||Lyophilized from sterile PBS, pH 7.4.
ORM2 Protein Usage Guide
|Storage:||Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.|
|Reconstitution:||A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.|
ORM2 Protein Related Products & Topics
ORM2 Protein Description
ORM2 is a member of the calycin superfamily, lipocalin family. Lipocalins are characterized by limited regions of sequence homology and a common tertiary structure architecture. They are associated with many biological processes and can be found in gram negative bacteria, vertebrate cells, and invertebrate cells, and in plants. Lipocalins transport small hydrophobic molecules such as steroids, bilins, retinoids, and lipids. ORM2 functions as transport protein in the blood stream. It is expressed by the liver and secreted in plasma. It appears to function in modulating the activity of the immune system during the acute-phase reaction. It binds various hydrophobic ligands in the interior of its beta-barrel domain. It also binds synthetic drugs and influences their distribution and availability.
- Lee MT. et al., 2009, Pharmacogenomics. 10 (12): 1905-11.
- Davila S. et al., 2010, Genes Immun. 11 (3): 232-8.
- Zhang X. et al., 2012, PLoS One. 7 (2): e31868.